Abbott Q2 MDx Sales Inch up 1 Percent
July 18, 2012
Abbott Q2 MDx Sales Inch up 1 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Dx Focus: Inostics OncoBEAM Blood Test; Abbott RealTime HPV Test; BioMérieux THxID BRAF assay
May 30, 2013 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Study Vets Abbott Plex-ID Platform as Tool for Broad Fungal ID Directly from Clinical Specimens
March 28, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - Abbott's MDx Sales Rise 4 Percent in Q4
January 23, 2013 / GenomeWeb Daily News